RPRX
Price:
$54.87
Market Cap:
$23.60B
Royalty Pharma plc, headquartered in New York City and founded in 1996, operates within the United States as a key player in the biopharmaceutical industry. The company primarily focuses on the acquisition of royalties from biopharmaceutical products and actively invests in funding new developments and innovations in the sector. Its activities involve diligently identifying, evaluating, and securing royalty agreements for a wide array of biopharmaceutical therapies. Beyond acquisitions, Royalty Pharma plc fosters collaborations with various innovators. These partners include academic institutions, research hospitals, non-profit organizations, small and mid-sized biotechnology firms, and larg...[Read more]
Industry
Biotechnology
IPO Date
2020-06-16
Stock Exchange
NASDAQ
Ticker
RPRX
According to Royalty Pharma plc’s latest financial reports and current stock price. The company's current Enterprise Value is 31.97B. This represents a change of 27.88% compared to the average of 25.00B of the last 4 quarters.
The mean historical Enterprise Value of Royalty Pharma plc over the last ten years is 22.49B. The current 31.97B Enterprise Value has changed 14.12% with respect to the historical average. Over the past ten years (40 quarters), RPRX's Enterprise Value was at its highest in in the March 2026 quarter at 29.09B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
22.49B
Median
21.92B
Minimum
18.06B
Maximum
31.24B
Discovering the peaks and valleys of Royalty Pharma plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 38.54%
Maximum Annual Enterprise Value = 31.24B
Minimum Annual Increase = -32.19%
Minimum Annual Enterprise Value = 18.06B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 25.02B | 38.54% |
| 2024 | 18.06B | -0.94% |
| 2023 | 18.23B | -19.73% |
| 2022 | 22.71B | 2.85% |
| 2021 | 22.08B | -8.87% |
| 2020 | 24.23B | 11.41% |
| 2019 | 21.75B | 6.86% |
| 2018 | 20.36B | -3.90% |
| 2017 | 21.18B | -32.19% |
| 2016 | 31.24B | -0.14% |
The current Enterprise Value of Royalty Pharma plc (RPRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.44B
5-year avg
21.22B
10-year avg
22.49B
Royalty Pharma plc’s Enterprise Value is greater than Genmab A/S (19.27B), greater than United Therapeutics Corporation (22.10B), greater than Incyte Corporation (18.26B), greater than Fresenius Medical Care AG & Co. KGaA (20.44B), greater than Summit Therapeutics Inc. (10.80B), greater than Smith & Nephew plc (15.69B), greater than Roivant Sciences Ltd. (20.29B), greater than Hologic, Inc. (17.32B), greater than Tenet Healthcare Corporation (25.29B), greater than Exelixis, Inc. (13.30B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 19.27B | $15.40B | |
| 22.10B | $23.17B | |
| 18.26B | $21.68B | |
| 20.44B | $12.36B | |
| 10.80B | $10.86B | |
| 15.69B | $12.97B | |
| 20.29B | $21.61B | |
| 17.32B | $16.97B | |
| 25.29B | $15.04B | |
| 13.30B | $13.35B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Royalty Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Royalty Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Royalty Pharma plc's Enterprise Value?
What is the highest Enterprise Value for Royalty Pharma plc (RPRX)?
What is the 3-year average Enterprise Value for Royalty Pharma plc (RPRX)?
What is the 5-year average Enterprise Value for Royalty Pharma plc (RPRX)?
How does the current Enterprise Value for Royalty Pharma plc (RPRX) compare to its historical average?